PharmaCyte Biotech Inc (PMCB)

[1234jklm]

We get first right of refusal and pay 40% of our future profit for it?

We paid 2 million for the license.

If they sell ciab we still own a license to it whoever buys ciab.

We own that license. It doesn't stop if ciab is sold.

This is selling shareholders down the road imho.

There is no need for this agreement.

If a future partner wants to own ciab they can negotiate directly with Austria sg to buy it.

Progress payments would be covered by our new partner.

This is another unfair agreement with austrianova which destroys shareholder value.

It just gives Austria sg more future revenue. A lot more.

And we pay 900,000usd for nothing.


An 11th hour agreement than benefits austrianova.